IDXX
IDEXX Laboratories, Inc. · Healthcare
President and CEO Jonathan Jay Mazelsky sold $15.3M of IDEXX Laboratories, Inc.
Sold$15,338,081
$657.55Price
23,326Shares
−22%Stake
What IDXX did after the filing
- The stock from Mon, Mar 2 close, $636.70
- −8.3%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Apr 14 close.
Traded Thu, Feb 26. Filed Mon, Mar 2, 12:00 PM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.